Exhibit 99.1
Aspyra Reports Results of Operations for the
Second Quarter Ended June 30, 2007
CALABASAS, Calif.--(BUSINESS WIRE)--Aug. 20, 2007--Aspyra, Inc.
(AMEX:APY), a provider of clinical and diagnostic information systems
for the healthcare industry, today reported its results of operations
for the second quarter ended June 30, 2007.
Sales were $2,650,657 for the second quarter, compared with sales
of $3,217,821 for the comparable quarter ended June 30, 2006. The
Company incurred a net loss of $893,656, or basic and diluted loss per
share of $.08, for the quarter ended June 30, 2007, compared with a
net loss of $1,064,180 or basic and diluted loss per share of $.11 for
the comparable quarter ended June 30, 2006. Basic and diluted shares
outstanding for each period were 10,787,150 and 9,614,200,
respectively.
Sales were $4,852,625 for the six months ended June 30, 2007,
compared with sales of $5,919,896 for the six months ended June 30,
2006. The Company incurred a net loss of $2,208,913, or basic and
diluted loss per share of $.20, for the six months ended June 30,
2007, compared with a net loss of $2,377,898, or basic and diluted
loss per share of $.26, for the comparable six-month period ended June
30, 2006. Basic and diluted shares outstanding for each period were
10,785,817 and 9,051,800, respectively.
Steven M. Besbeck stated, "The results of operations for the
second fiscal quarter were an improvement over the comparable period
even though we recognized less revenue associated with sales of
clinical and diagnostic imaging systems. For the first half of this
fiscal year we experienced slow contract signings as the marketplace
adjusted to changes in the reimbursement for some imaging procedures
as the result of the enactment of the Deficit Reduction Act (DRA) in
the fourth quarter of 2006. However, we began to experience improved
sales closings and new opportunities for potential sales late in our
second quarter that is helping to build a larger pipeline of
business."
Aspyra is a global provider of Health Care Information Technology
(HCIT) solutions and services to the healthcare industry. The Company
specializes in Clinical Information Systems (CIS), Picture Archive
Communication Systems (PACS) and Clinical Image Management Systems
(CIMS) for hospitals, multi-specialty clinics, clinical laboratories,
imaging departments and centers, orthopedic environments and
pharmacies. Aspyra's highly scalable systems can be installed
standalone or integrated to provide a single-vendor, enterprise-wide
solution. For more information on Aspyra, its products and services,
visit www.aspyra.com.
Safe Harbor Statement
This press release includes forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995,
including statements related to anticipated revenues, expenses,
earnings, operating cash flows, the outlook for Aspyra's markets and
the demand for its products. Forward-looking statements are not
guarantees of future performance and are inherently subject to
uncertainties and other factors which could cause actual results to
differ materially from the forward-looking statement. Such statements
are based upon, among other things, assumptions made by, and
information currently available to, management as of today, August 20,
2007, including management's own knowledge and assessment of the
Company's industry and competition. Factors that could cause Aspyra's
actual results to differ materially from these forward-looking
statements include among others: whether the combined company will
realize the potential benefits of the merger; the competitive
environment; unexpected technical and marketing difficulties inherent
in major product development efforts; the potential need for changes
in our long-term strategy in response to future developments; future
advances in clinical information technology and procedures, as well as
potential changes in government regulations and healthcare policies;
and rapid technological change in the microelectronics and software
industries. The Company refers interested persons to its most recent
Annual Report on Form 10-KSB and its other SEC filings for a
description of additional uncertainties and factors, which may affect
forward-looking statements. The Company assumes no duty to update its
forward-looking statements.
Consolidated Statement of Operations
Second Quarter Six Months
Ended June 30, Ended June 30,
2007 2006 2007 2006
---------- ---------- ---------- ----------
Net Sales $ 2,650,657 $ 3,217,821 $ 4,852,625 $ 5,919,896
Net Loss $ (893,656) $(1,064,180) $(2,208,913) $(2,377,898)
Net Loss per Share
- Basic and
Diluted $ (0.08) $ (0.11) $ (0.20) $ (0.26)
Average Shares
Outstanding -
Basic and Diluted 10,787,150 9,614,200 10,785,817 9,051,800
CONTACT: Aspyra, Inc.
Steven M. Besbeck, President and CEO
818.880.6700 x8660